Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Netrin-G1 is a member of the netrin protein family, structurally distinct from classical secreted netrins due to its glycosyl phosphatidylinositol (GPI) membrane anchoring. There are at least six isoforms, mostly restricted to the central nervous system. Unlike classical netrins, netrin-G1 has unique C-terminal hydrophobic regions that facilitate its membrane association, and it does not show detectable affinity for standard netrin receptors. Netrin-G1 acts in axon guidance, synaptic specificity, and the formation of neural circuits. It is expressed in specific CNS neurons (notably thalamic relay neurons) and is crucial for proper synapse formation, dendritic patterning, and mechanosensory end organ assembly. Its ligand, NGL-1, is a postsynaptic adhesion protein facilitating trans-synaptic signaling. Mutations affecting netrin-G1 or its ligand NGL-1 are implicated in several neurodevelopmental pathologies, suggesting netrin-G1's critical role in the establishment and maintenance of functional neural networks[1][2][3].
Not applicable (no drug mechanism of action documented for this molecule)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Netrin-G1.